This inflammation of the colon poses a substantial burden to patients and the health care system.
Monique R. Bidell, PharmD, BCPS
Advertisement
Articles by Monique R. Bidell, PharmD, BCPS
Advertisement
Latest Updated Articles
Access to C. difficile Treatments Presents Challenges During Transitions of CarePublished: July 20th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
3
FDA Updates Boxed Warning for Cilta-Cel Following Reports of Immune Effector Cell–Associated Enterocolitis
4
Medetomidine: The Demon in the Illicit Fentanyl Supply
5
